10x Genomics, Inc. (TXG)
NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
At close: 04:00PM EDT
Pre-market:
| Previous close | 22.59 |
| Open | 22.83 |
| Bid | 22.63 x 300 |
| Ask | 22.72 x 300 |
| Day's range | 22.24 - 22.90 |
| 52-week range | 22.24 - 63.57 |
| Volume | |
| Avg. volume | 1,643,695 |
| Market cap | 2.717B |
| Beta (5Y monthly) | 1.94 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -2.25 |
| Earnings date | 01 Aug 2024 - 05 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 41.23 |
ZacksInternational Markets and 10x Genomics (TXG): A Deep Dive for Investors
Review 10x Genomics' (TXG) international revenue performance and how it affects the predictions of financial analysts on Wall Street and the future prospects for the stock.
PR Newswire10x Genomics to Present at the BofA Securities 2024 Healthcare Conference
10x Genomics, Inc. (Nasdaq: TXG), a leader in single cell and spatial biology, today announced that members of its management team will participate in a fireside chat at the BofA Securities 2024 Healthcare Conference on Tuesday, May 14, at 4:20 p.m. Pacific Time.
Simply Wall St.10x Genomics First Quarter 2024 Earnings: In Line With Expectations
10x Genomics ( NASDAQ:TXG ) First Quarter 2024 Results Key Financial Results Revenue: US$141.0m (up 5.0% from 1Q 2023...
© 2024 Yahoo. All rights reserved.